글로벌 메타게놈학 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 메타게놈 시장

메타게놈학 시장은 2021년부터 2028년까지의 예측 기간 동안 7.3%의 시장 성장을 목격할 것으로 예상됩니다. 메타게놈학 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 의료 부문이 확대되면서 메타게놈학 시장의 성장이 가속화되고 있습니다.

메타게놈학은 환경 샘플에서 회수한 유전 물질에 대한 연구로 불립니다. 이 연구는 유전자와 미생물 경로를 연구하는 것을 목표로 하는 미생물 군집을 위한 도구로 정의됩니다. 그것은 전체 생명체 세계를 이해할 수 있는 잠재력을 가진 강력한 렌즈를 제공합니다. 이 기술은 미생물 생태학에 대한 이해를 높이고 연구자들이 방대한 미생물 다양성을 활용할 수 있게 합니다.

전 세계적으로 유전적 질환 의 유병률 증가는 메타게놈학 시장 성장을 견인하는 주요 요인 중 하나로 작용합니다. 대규모 시퀀싱 프로젝트를 위한 정부 및 민간 기관의 이니셔티브와 자금 지원의 급증, 메타게놈학 및 마이크로바이옴 프로파일링을 지원하는 생물정보학 플랫폼 개발에 대한 투자는 시장 성장을 가속화합니다. 메타전사체학, 메타단백질체학 및 대사체학과 같은 관련 신규 연구 분야에 대한 연구자들의 관심 증가와 다양한 분야에서 메타게놈학의 중요한 응용 분야는 시장에 더욱 영향을 미칩니다. 또한 치과 수술에 대한 높은 수요, 의료 및 치과 관광의 증가, 노인 인구의 증가 및 개발도상국의 가처분 소득의 급증은 메타게놈학 시장에 긍정적인 영향을 미칩니다. 또한 데이터 관리를 위한 클라우드 컴퓨팅의 가용성은 2021년에서 2028년까지의 예측 기간 동안 시장 참여자에게 수익성 있는 기회를 확대합니다.

On the other hand, end-user budget constraints in developing countries and high cost of the technolohy are expected to obstruct the market growth. Storage of sequencing data and dearth of skilled professionals are projected to challenge the metagenomics market in the forecast period of 2021-2028.

This metagenomics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on metagenomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Metagenomics Market Scope and Market Size

• The metagenomics market is segmented on the basis of product and service, workflow, technology and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 
• On the basis of product and service, the metagenomics market is segmented into reagents and consumables, instruments, services, and analysis and data interpretation solutions.
• On the basis of workflow, the metagenomics market is segmented into sample processing and library preparation, sequencing, and data processing and analysis.
• On the basis of technology, the metagenomics market is segmented into shotgun metagenomic sequencing, 16S rRNA sequencing, metatranscriptomics, whole-genome sequencing and de novo assembly.
• On the basis of application, the metagenomics market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological and environmental applications, veterinary applications and other applications.

Metagenomics Market Country Level Analysis

The metagenomics market is analyzed and market size insights and trends are provided by country, product and service, workflow, technology and application as referenced above.      

The countries covered in the metagenomics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the metagenomics market because of the presence of a substantial number of prominent biotechnology companies within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the developments undertaken to strengthen the bioinformatics infrastructure and genomic landscape in countries such as India and China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The metagenomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for metagenomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the metagenomics market. The data is available for historic period 2010-2019.

Competitive Landscape and Metagenomics Market Share Analysis

The metagenomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to metagenomics market.

메타게놈학 시장 보고서에서 다루는 주요 기업으로는 Agilent Technologies, Inc, ENTEROME, IntegraGen, Oxford Nanopore Technologies, QIAGEN, Illumina, Inc, Pacific Biosciences of California, Inc, Swift Biosciences Inc., Thermo Fisher Scientific Inc., BGI, Bio-Rad Laboratories, Inc., Promega Corporation 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-50324